{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:12:23Z","timestamp":1786997543846,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.tiv.2013.09.016","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T18:03:50Z","timestamp":1379786630000},"page":"2203-2212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Confirmation of in vitro and clinical safety assessment of behentrimonium chloride-containing leave-on body lotions using post-marketing adverse event data"],"prefix":"10.1016","volume":"27","author":[{"given":"D.M.","family":"Cameron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.-E.","family":"Costin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Avalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.L.","family":"Billhimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gilpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Simion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2013.09.016_b0005","series-title":"Alternative Methods in Toxicology","first-page":"131","article-title":"An Improved CAM method for predicting ocular irritation","volume":"vol. 6","author":"Bagley","year":"1988"},{"key":"10.1016\/j.tiv.2013.09.016_b0010","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/0278-6915(94)90131-7","article-title":"Development of a 10-day chorioallantoic membrane vascular assay as an alternative to the Draize rabbit eye irritation test","volume":"33","author":"Bagley","year":"1994","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tiv.2013.09.016_b0015","series-title":"Handbook of Cosmetic Science and Technology","author":"Barel","year":"2009"},{"key":"10.1016\/j.tiv.2013.09.016_b0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/15569528209051516","article-title":"A reappraisal of the 21-day cumulative irritation test in man","volume":"1","author":"Berger","year":"1982","journal-title":"J. Toxicol. Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.tiv.2013.09.016_b0025","first-page":"14","article-title":"The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts","volume":"4","author":"Berridge","year":"1996","journal-title":"Biochemica"},{"key":"10.1016\/j.tiv.2013.09.016_b0030","first-page":"443","article-title":"The 21-day human cumulative irritation test can be reduced to 14 days without loss of sensitivity","volume":"54","author":"Bowman","year":"2003","journal-title":"J. Cosmet. Sci."},{"key":"10.1016\/j.tiv.2013.09.016_b0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/15569529609048870","article-title":"A novel approach to assessing eye irritation potential using the bovine corneal opacity and permeability assay","volume":"15","author":"Casterton","year":"1996","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"1","key":"10.1016\/j.tiv.2013.09.016_b0040","first-page":"106","article-title":"CAMVA validation as an alternative to the Draize ocular: Part 2, alcohols and alcohol containing products","volume":"12","author":"Cerven","year":"1992","journal-title":"Toxicologist"},{"key":"10.1016\/j.tiv.2013.09.016_b0045","unstructured":"CIR, 2010. Trimoniums as used in cosmetics (final report). In: Cosmetic Ingredient Review (CIR) Expert Panel, Washington, DC."},{"key":"10.1016\/j.tiv.2013.09.016_b0050","unstructured":"Colipa, 2008. Colipa guidelines on the management and reporting of undesirable event reports in the context of EU cosmetovigilance. First updated version, adopted 15 May 2008. The European Cosmetic, Toiletry, and Perfumery Association (Colipa). <http:\/\/www.likochema.lt\/docs\/naujienos\/COSVIG_Guidelines_updated.pdf> (accessed 22.03.13)."},{"key":"10.1016\/j.tiv.2013.09.016_b0055","unstructured":"Colipa, 2011. Colipa Residential Training Workshop: Practical Aspects of the EU Cosmetics Regulation, Brussels, 7\u20139 November, 2011."},{"key":"10.1016\/j.tiv.2013.09.016_b0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tiv.2010.12.003","article-title":"Survey of ocular irritation predictive capacity using Chorioallantoic Membrane Vascular Assay (CAMVA) and Bovine Corneal Opacity and Permeability (BCOP) test historical data for 319 personal care products over fourteen years","volume":"25","author":"Donahue","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2013.09.016_b0070","series-title":"Patch Testing","author":"Fregert","year":"1975"},{"key":"10.1016\/j.tiv.2013.09.016_b0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0190-9622(79)70001-6","article-title":"The soap chamber test","volume":"1","author":"Frosch","year":"1979","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tiv.2013.09.016_b0080","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0272-0590(92)90142-5","article-title":"Bovine corneal opacity and permeability test: an in vitro assay of ocular irritancy","volume":"18","author":"Gautheron","year":"1992","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2013.09.016_b0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2340\/00015555724244","article-title":"Moisturizers prevent irritant dermatitis","volume":"72","author":"Hannuksela","year":"1992","journal-title":"Acta Derm. Venereol. (Stockh.)"},{"key":"10.1016\/j.tiv.2013.09.016_b0090","unstructured":"Harrison, L.B., 2008. Phototoxicity and Photoallergenicity Test. Harrison Research Laboratories Inc., Union, NJ. Unpublished Study 08-170-HRL dated 07.17.2008."},{"key":"10.1016\/j.tiv.2013.09.016_b0095","unstructured":"ICCVAM, 2006a. Test Method Evaluation Report \u2013 In Vitro Ocular Toxicity Test Methods for Identifying Ocular Severe Irritants and Corrosives. Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), NIH Publication No.: 07-4517. National Toxicology Program, Research Triangle Park. <http:\/\/iccvam.niehs.nih.gov\/docs\/ocutox_docs\/OTeval\/OTevalrpt.pdf> (accessed 22.03.13)."},{"key":"10.1016\/j.tiv.2013.09.016_b0100","unstructured":"ICCVAM, 2006b. Current Status of In Vitro Test Methods for Identifying Ocular Corrosives and Severe Irritants: Bovine Corneal Opacity and Permeability Test Method. Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), NIH Publication No.: 06-4512. National Toxicology Program, Research Triangle Park. <http:\/\/iccvam.niehs.nih.gov\/docs\/ocutox_docs\/ocubrd\/bcop\/bcopbrd.pdf> (accessed 22.03.13)."},{"key":"10.1016\/j.tiv.2013.09.016_b0105","unstructured":"ICH, 1996. International Conference on Harmonization (ICH) Tripartite Guidelines for Good Clinical Practice. Directive 91\/507\/EEC, the Rules Governing Medicinal Products in the European Community. <http:\/\/www.ikev.org\/docs\/eu\/391L0507.htm> (accessed 22.03.13)."},{"key":"10.1016\/j.tiv.2013.09.016_b0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0536.1977.tb03582.x","article-title":"The development of allergic contact dermatitis in females during the comparison of two predictive patch tests","volume":"3","author":"Jordan","year":"1977","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.tiv.2013.09.016_b0115","unstructured":"Lanman, B.M., Elvers, W.B., Howard, C.S., 1968. The role of human patch testing in the product development program. In: Proceedings of the Joint Conference on Cosmetics Science, The Toilet Goods Association (currently the Cosmetic, Toiletry and Fragrance Association), Washington, DC, April 21\u201323, 1968, pp. 135\u2013145."},{"key":"10.1016\/j.tiv.2013.09.016_b0120","first-page":"99","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2013.09.016_b0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000231524","article-title":"Variation of skin surface pH, sebum content and stratum corneum hydration with age and gender in a large Chinese population","volume":"22","author":"Man","year":"2009","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.tiv.2013.09.016_b0130","first-page":"399","article-title":"Antimicrobials: experimental contact sensitization in man","volume":"24","author":"Marzulli","year":"1973","journal-title":"J. Soc. Cosmet. Chem."},{"key":"10.1016\/j.tiv.2013.09.016_b0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0015-6264(74)90367-8","article-title":"The use of graded concentrations in studying skin sensitization: experimental contact sensitization in man","volume":"12","author":"Marzulli","year":"1974","journal-title":"Food Cosmet. Toxicol."},{"key":"10.1016\/j.tiv.2013.09.016_b0140","first-page":"235","article-title":"Contact allergy: predictive testing of fragrance ingredients in humans by Draize and Maximization methods","volume":"3","author":"Marzulli","year":"1980","journal-title":"J. Environ. Pathol. Toxicol."},{"key":"10.1016\/j.tiv.2013.09.016_b0145","unstructured":"OECD, 1998. Principles of good laboratory practice (as revised in 1997), ENV\/MC\/CHEM(98)17, C(97)186\/Final. Organisation for Economic Co-operation and Development, Paris. <http:\/\/www.oecd-ilibrary.org\/environment\/oecd-principles-on-good-laboratory-practice_9789264078536-en> (accessed 22.03.13)."},{"key":"10.1016\/j.tiv.2013.09.016_b0150","unstructured":"OECD, 2009. Bovine Corneal Opacity and Permeability (BCOP) Test Method for Identifying Ocular Corrosives and Severe Irritants. Test Guideline 437, Organisation for Cooperation and Development, adopted 7 September 2009. <http:\/\/www.oecd-ilibrary.org\/environment\/test-no-437-bovine-corneal-opacity-and-permeability-test-method-for-identifying-ocular-corrosives-and-severe-irritants_9789264076303-en> (accessed 22.03.13)."},{"key":"10.1016\/j.tiv.2013.09.016_b0155","unstructured":"OECD, 2010. In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method. Test Guideline 439, Organisation for Cooperation and Development, adopted 22 July 2010. <http:\/\/www.oecd-ilibrary.org\/environment\/test-no-439-in-vitro-skin-irritation_9789264090958-en> (accessed 22.03.13)."},{"key":"10.1016\/j.tiv.2013.09.016_b0160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0041-008X(72)90157-3","article-title":"Comparison of rabbit and human skin responses to certain irritants","volume":"21","author":"Phillips","year":"1972","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2013.09.016_b0220","series-title":"Similarities between Children and Adults, Implications for Risk Assessment","first-page":"79","article-title":"Differences between children and adults affecting exposure assessment","author":"Plunkett","year":"1992"},{"key":"10.1016\/j.tiv.2013.09.016_b0170","unstructured":"Redden, J., Perry, M. J., Leighton, T., Chen, J., McMahon, T., 2009. Voluntary Pilot Program to Evaluate Use of a Non-Animal Testing Approach to EPA Labeling for Eye Irritation for Certain Antimicrobial Products with Cleaning Claims. United States Environmental Protection Agency, Office of Pesticide Programs, Washington, DC. <http:\/\/www.epa.gov\/oppad001\/eye-irritation.pdf> (accessed 22.03.13)."},{"key":"10.1016\/j.tiv.2013.09.016_b0175","unstructured":"SCCS, 2009. Opinion on alkyl (C16, C18, C22) trimethylammonium chloride for other uses than as a preservative, SCCS\/1246\/09, adopted by the SCCS on 8 December 2009. Scientific Committee on Consumer Safety (SCCS), European Commission. <http:\/\/ec.europa.eu\/health\/scientific_committees\/consumer_safety\/docs\/sccs_o_012.pdf> (accessed 22.03.13)."},{"key":"10.1016\/j.tiv.2013.09.016_b0180","series-title":"Handbook of Non-Invasive Methods and the Skin","year":"1995"},{"key":"10.1016\/j.tiv.2013.09.016_b0185","first-page":"253","article-title":"In vitro ocular irritancy prediction: assays in serum-free medium correlate better with in vivo data","volume":"vol. 6","author":"Shopsis","year":"1988"},{"key":"10.1016\/j.tiv.2013.09.016_b0190","first-page":"427","article-title":"Ability of moisturizers to reduce dry skin and irritation and to prevent their return","volume":"56","author":"Simion","year":"2005","journal-title":"J. Cosmet. Sci."},{"key":"10.1016\/j.tiv.2013.09.016_b0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/faat.1995.1071","article-title":"A collaborative evaluation of seven alternatives to the Draize eye irritation test using pharmaceutical intermediates","volume":"26","author":"Sina","year":"1995","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2013.09.016_b0230","series-title":"Voluntary filing of cosmetic product experiences (21CFR730)","volume":"vol. 7(Part 730)","author":"U.S. FDA","year":"1996"},{"key":"10.1016\/j.tiv.2013.09.016_b0225","series-title":"Frequency of use of cosmetic ingredients","author":"U.S. FDA","year":"2009"},{"key":"10.1016\/j.tiv.2013.09.016_b0215","first-page":"241","article-title":"Moisturizers in preventing irritant contact dermatitis: an overview","volume":"38","author":"Zhai","year":"1998","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.tiv.2013.09.016_b0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0846.2000.006002077.x","article-title":"A bioengineering study on the efficacy of a skin protectant lotion in preventing SLS-induced dermatitis","volume":"6","author":"Zhai","year":"2000","journal-title":"Skin Res. Technol."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313002257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313002257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:31:13Z","timestamp":1715981473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233313002257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0887233313002257"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2013.09.016","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Confirmation of in vitro and clinical safety assessment of behentrimonium chloride-containing leave-on body lotions using post-marketing adverse event data","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2013.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}